HERPES ZOSTER IN BARICITINIB-TREATED JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS USING REAL-WORLD CLINICAL DATA

被引：0
|
作者：
Torikai, E. [1 ]
Hirano, Y. [2 ]
Suzuki, D. [3 ]
Kanayama, Y. [4 ]
机构：
[1] Iwata City Hosp, Iwata, Japan
[2] Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan
[3] Futaba Clin, Iwata, Japan
[4] Toyota Kosei Hosp, Toyota, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.3023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0362
引用
收藏
页码：1478 / 1478
页数：1
相关论文
共 50 条
  • [1] Herpes Zoster in Patients with Moderate to Severe Rheumatoid Arthritis Treated with Baricitinib
    Winthrop, Kevin L.
    Lindsey, Stephen
    Weinblatt, Michael
    Takeuchi, Tsutomu
    Hyslop, David
    Issa, Maher
    Chen, Lei
    Bradley, John
    Dickson, Christina
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] Real-world observational study of patients with rheumatoid arthritis treated with baricitinib or tofacitinib in a tertiary hospital
    Guillen Benitez, Elena
    Sabate Gallego, Monica
    Ballarin Alins, Elena
    Espartal Lopez, Esther
    Lopez Lasanta, Maria
    Bosch Ferrer, Montserrat
    Artilagas Boixareu, Nuria
    Alerany Pardo, Carmen
    Danes Carreras, Immaculada
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 16 - 17
  • [3] LOW JOINT DAMAGE PROGRESSION RATES IN BARICITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS
    van der Heijde, D.
    Schiff, M.
    Tanaka, Y.
    Klar, R.
    Xie, L.
    Meszaros, G.
    Ishii, T.
    Casillas, M.
    Ortmann, R.
    Emery, P.
    Moyano, S.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S84 - S84
  • [4] SURVIVAL RATE OF BARICITINIB IN A LARGE COHORT OF RHEUMATOID ARTHRITIS PATIENTS: ANALYSIS OF REAL-WORLD DATA
    Parisi, S.
    Becciolini, A.
    Ditto, M. C.
    Del Medico, P.
    Farina, A.
    Visalli, E.
    Colella, A. Molica
    Lumetti, F.
    Caccavale, R.
    Scolieri, P.
    Andracco, R.
    Girelli, F.
    Bravi, E.
    Colina, M.
    Volpe, A.
    Ianniello, A.
    Nucera, V.
    Franchina, V.
    Plate, I.
    Di Donato, E.
    Amato, G.
    Salvarani, C.
    Gardelli, L.
    Lucchini, G.
    De Lucia, F.
    Colella, F. Molica
    Priora, M.
    Santilli, D.
    Mansueto, N.
    Ferrero, G.
    Rovera, G.
    Fiorenza, A.
    Vitetta, R.
    Marchetta, A.
    Ravagnani, V.
    Paroli, M.
    Bernardi, S.
    Arrigoni, E.
    Foti, R.
    Sandri, G.
    Bruzzese, V.
    Ometto, F.
    Bezzi, A.
    Focherini, M. C.
    Adorni, G.
    Mascella, F.
    Lo Gullo, A.
    Bianchi, G.
    Camellino, D.
    Larosa, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1415 - 1416
  • [5] EFFICACY AND SAFETY UP TO 24 WEEKS OF BARICITINIB FOR JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL WORLD MULTICENTER CLINICAL DATA
    Torikai, Eiji
    Suzuki, Daisuke
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 375 - 376
  • [6] INCIDENCE OF HERPES ZOSTER AND MALIGNANCY IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ETANERCEPT
    Takeuchi, T.
    Sugiyama, N.
    Miyasaka, N.
    Morishima, Y.
    Yuasa, H.
    Sugiyama, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 220 - 221
  • [7] EFFICACY AND SAFETY OF BARICITINIB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM REAL-WORLD
    Gonzalez Mazario, R.
    Fragio-Gil, J. J.
    Grau Garcia, E.
    De la Rubia Navarro, M.
    Pavez Perales, C.
    Leal Rodriguez, S.
    Ivorra Cortes, J.
    Negueroles Albuixech, R.
    Gonzalez Puig, L.
    Oller Rodriguez, J. E.
    Alcaniz Escandell, C.
    Vicens Bernabeu, E.
    Chalmeta Verdejo, I.
    Martinez Cordellat, I.
    Ortiz Sanjuan, F. M.
    Najera Herranz, C.
    Canovas Olmos, I.
    Canada Martinez, A. J.
    Roman Ivorra, J. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 639 - 640
  • [8] Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Sato, Shuntaro
    Kurushima, Shota
    Michitsuji, Toru
    Nishihata, Shinya
    Okamoto, Momoko
    Tsuji, Yoshika
    Endo, Yushiro
    Shimizu, Toshimasa
    Sumiyoshi, Remi
    Suzuki, Takahisa
    Okada, Akitomo
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Fujikawa, Keita
    Igawa, Takashi
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Mizokami, Akinari
    Origuchi, Tomoki
    Ueki, Yukitaka
    Eguchi, Katsumi
    Kawakami, Atsushi
    [J]. ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [9] Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
    Naoki Iwamoto
    Shuntaro Sato
    Shota Kurushima
    Toru Michitsuji
    Shinya Nishihata
    Momoko Okamoto
    Yoshika Tsuji
    Yushiro Endo
    Toshimasa Shimizu
    Remi Sumiyoshi
    Takahisa Suzuki
    Akitomo Okada
    Tomohiro Koga
    Shin-ya Kawashiri
    Keita Fujikawa
    Takashi Igawa
    Toshiyuki Aramaki
    Kunihiro Ichinose
    Mami Tamai
    Hideki Nakamura
    Akinari Mizokami
    Tomoki Origuchi
    Yukitaka Ueki
    Katsumi Eguchi
    Atsushi Kawakami
    [J]. Arthritis Research & Therapy, 23
  • [10] Herpes zoster in patients with inflammatory arthritides or ulcerative colitis treated with tofacitinib, baricitinib or upadacitinib: a systematic review of clinical trials and real-world studies
    Chrysoula G. Gialouri
    Savvina Moustafa
    Konstantinos Thomas
    Emilia Hadziyannis
    Dimitrios Vassilopoulos
    [J]. Rheumatology International, 2023, 43 : 421 - 435
12345